glucose, (beta-d)-isomer has been researched along with moxifloxacin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hand, DL; Hand, WL; Vasquez, Y | 1 |
| Brand, T; Breithaupt-Groegler, K; Broedl, UC; Macha, S; Ring, A; Simons, G; Walter, B; Woerle, HJ | 1 |
| Abeyratne, A; Dietz, A; Kadokura, T; Keirns, J; Krauwinkel, W; Smulders, R; Zhang, W | 1 |
| Alam, SM; Alothman, ZA; Alqadami, AA; Naushad, M; Siddiqui, MR; Wabaidur, SM | 1 |
2 trial(s) available for glucose, (beta-d)-isomer and moxifloxacin
| Article | Year |
|---|---|
The sodium glucose cotransporter 2 inhibitor empagliflozin does not prolong QT interval in a thorough QT (TQT) study.
Topics: Action Potentials; Adolescent; Adult; Benzhydryl Compounds; Cross-Over Studies; Double-Blind Method; Electrocardiography; Female; Fluoroquinolones; Germany; Glucosides; Heart Conduction System; Heart Rate; Humans; Hypoglycemic Agents; Long QT Syndrome; Male; Middle Aged; Moxifloxacin; Risk Assessment; Risk Factors; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Time Factors; Young Adult | 2013 |
Ipragliflozin does not prolong QTc interval in healthy male and female subjects: a phase I study.
Topics: Adult; Aza Compounds; Black or African American; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Electrocardiography; Female; Fluoroquinolones; Glucosides; Healthy Volunteers; Heart Conduction System; Heart Rate; Humans; Male; Middle Aged; Moxifloxacin; Quinolines; Thiophenes; White People; Young Adult | 2013 |
2 other study(ies) available for glucose, (beta-d)-isomer and moxifloxacin
| Article | Year |
|---|---|
Increased polymorphonuclear leukocyte respiratory burst function in type 2 diabetes.
Topics: Anti-Bacterial Agents; Aza Compounds; Azithromycin; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Fluoroquinolones; Humans; Male; Mexican Americans; Moxifloxacin; Neutrophils; Ofloxacin; Protein Kinase C; Quinolines; Respiratory Burst; Superoxides; Tetradecanoylphorbol Acetate; Zymosan | 2007 |
Flow-injection chemiluminescence method for the determination of moxifloxacin in pharmaceutical tablets and human urine using silver nanoparticles sensitized calcein-KMnO4 system.
Topics: Anti-Bacterial Agents; Flow Injection Analysis; Fluoresceins; Fluoroquinolones; Glucosides; Humans; Luminescent Measurements; Manganese Compounds; Metal Nanoparticles; Moxifloxacin; Oxides; Reproducibility of Results; Sensitivity and Specificity; Silver; Tablets; Technology, Pharmaceutical; Urinalysis | 2015 |